Dan Wang

11.5k total citations · 1 hit paper
314 papers, 8.8k citations indexed

About

Dan Wang is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Dan Wang has authored 314 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Molecular Biology, 85 papers in Biomedical Engineering and 60 papers in Biomaterials. Recurrent topics in Dan Wang's work include Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (39 papers) and Neuroscience and Neuropharmacology Research (16 papers). Dan Wang is often cited by papers focused on Nanoparticle-Based Drug Delivery (40 papers), Nanoplatforms for cancer theranostics (39 papers) and Neuroscience and Neuropharmacology Research (16 papers). Dan Wang collaborates with scholars based in China, United States and Australia. Dan Wang's co-authors include Lingyun Zhao, Zhenhu Guo, Fei Gao, Qin Gao, Xiumei Wang, He Liu, Wensheng Xie, Robert O. Messing, Wensheng Xie and Shibin Shang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Dan Wang

301 papers receiving 8.7k citations

Hit Papers

Inhalable biohybrid microrobots: a non-invasive approach ... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dan Wang China 53 2.9k 2.6k 1.8k 1.3k 976 314 8.8k
Viness Pillay South Africa 55 3.2k 1.1× 2.0k 0.8× 3.7k 2.0× 1.1k 0.8× 410 0.4× 303 11.6k
Xu Zhang China 52 3.1k 1.1× 3.7k 1.4× 1.7k 0.9× 2.1k 1.6× 520 0.5× 317 9.9k
José Luís Pedraz Spain 60 3.7k 1.3× 4.3k 1.7× 3.4k 1.8× 721 0.5× 754 0.8× 387 13.7k
Yahya E. Choonara South Africa 53 3.3k 1.1× 2.0k 0.8× 3.7k 2.0× 1.0k 0.8× 434 0.4× 384 11.1k
Jihoon Kim South Korea 41 2.9k 1.0× 2.1k 0.8× 1.4k 0.8× 1.2k 0.9× 434 0.4× 161 6.9k
Lino Ferreira Portugal 53 3.5k 1.2× 4.2k 1.6× 2.7k 1.5× 930 0.7× 727 0.7× 171 10.2k
Roger W. Beuerman Singapore 64 1.6k 0.5× 3.4k 1.3× 1.5k 0.8× 747 0.6× 598 0.6× 338 15.2k
Anwarul Hasan Qatar 58 5.5k 1.9× 2.4k 0.9× 4.6k 2.5× 2.2k 1.6× 326 0.3× 280 13.1k
Jin Zhang China 63 4.6k 1.6× 3.5k 1.4× 2.6k 1.4× 2.0k 1.5× 571 0.6× 423 14.0k
Wenxin Wang China 63 3.6k 1.2× 3.6k 1.4× 3.6k 2.0× 1.9k 1.4× 380 0.4× 530 14.2k

Countries citing papers authored by Dan Wang

Since Specialization
Citations

This map shows the geographic impact of Dan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Wang more than expected).

Fields of papers citing papers by Dan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Wang. The network helps show where Dan Wang may publish in the future.

Co-authorship network of co-authors of Dan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Wang. A scholar is included among the top collaborators of Dan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Wang. Dan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Ye, Lei, Zhenzhen Cui, Dan Wang, et al.. (2024). Discovery of a potent Gilteritinib-based FLT3-PROTAC degrader for the treatment of Acute myeloid leukemia. Bioorganic Chemistry. 149. 107477–107477. 5 indexed citations
3.
Li, Jun, Shujun Zhang, Yingnan Zhao, et al.. (2024). Chemical constituents from the leaves of Scutellaria baicalensis Georgi and their chemotaxonomic significance. Biochemical Systematics and Ecology. 116. 104885–104885. 1 indexed citations
4.
Zhao, Yuanyuan, Yubin Wang, Dan Wang, et al.. (2024). Different microbiota modulation and metabolites generation of five dietary glycans during in vitro gut fermentation are determined by their monosaccharide profiles. Food Research International. 196. 115011–115011. 8 indexed citations
5.
Wang, Dan, et al.. (2024). Functional groups effect on the toxicity of modified ZIF-90 to Photobacterium phosphoreum. Chemosphere. 351. 141188–141188. 2 indexed citations
6.
Zhang, Peng, et al.. (2024). Formation mechanism of an ultra-low thermal conductivity thermal barrier coating deposited using biomimetic hierarchical porous microspheres. Journal of the European Ceramic Society. 45(2). 116862–116862. 2 indexed citations
7.
Chen, Yu, Runguo Zheng, Zhiyuan Wang, et al.. (2024). Dual-element substitution induced integrated defect structure to suppress voltage decay and capacity fading of Li-rich Mn-based cathode. Journal of Colloid and Interface Science. 677(Pt B). 377–386. 5 indexed citations
8.
Hong, Chao, Anni Wang, Jiaxuan Xia, et al.. (2024). Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy. International Journal of Nanomedicine. Volume 19. 2879–2888. 10 indexed citations
9.
Zhou, Wei, Pengqi Wang, Dan Wang, et al.. (2024). Pharmacologically inducing regenerative cardiac cells by small molecule drugs. eLife. 13. 2 indexed citations
10.
Zhang, Yujie, Jingjie Zhao, Lingmin Zhang, et al.. (2023). A cascade nanoreactor for enhancing sonodynamic therapy on colorectal cancer via synergistic ROS augment and autophagy blockage. Nano Today. 49. 101798–101798. 76 indexed citations
11.
Wang, Xiaowei, Hongwei Lü, Fang Luo, et al.. (2023). Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Journal of Controlled Release. 365. 112–131. 10 indexed citations
12.
13.
Ai, Xiangzhao, Dan Wang, Ilkoo Noh, et al.. (2023). Glycan-modified cellular nanosponges for enhanced neutralization of botulinum toxin. Biomaterials. 302. 122330–122330. 9 indexed citations
14.
Wang, Dan, et al.. (2023). Reversal Effect of Saikosaponin A and Saikosaponin B on Doxorubicin-resistant Breast Cancer Cells and its Mechanism. Pharmacognosy Magazine. 19(3). 700–708. 1 indexed citations
15.
Hu, Yanyan, Yuanyuan Yang, Pengcheng Tan, et al.. (2022). Induction of mouse totipotent stem cells by a defined chemical cocktail. Nature. 617(7962). 792–797. 67 indexed citations
16.
Xu, Mengze, Bin Xue, Yue Wang, et al.. (2021). Temperature‐Feedback Nanoplatform for NIR‐II Penta‐Modal Imaging‐Guided Synergistic Photothermal Therapy and CAR‐NK Immunotherapy of Lung Cancer. Small. 17(43). e2101397–e2101397. 64 indexed citations
17.
Yang, Tingting, Chune Ren, Chao Lü, et al.. (2019). Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer. Cancer Research. 79(20). 5233–5244. 72 indexed citations
18.
Wang, Shi, Lingyun Zhao, Dan Wang, et al.. (2019). Multifunction bismuth gadolinium oxide nanoparticles as radiosensitizer in radiation therapy and imaging. Physics in Medicine and Biology. 64(19). 195007–195007. 39 indexed citations
19.
Shi, Yujie, Dong Peng, Dan Wang, et al.. (2019). <p>Biodistribution Survey of Oxidized Single-Wall Carbon Nanohorns Following Different Administration Routes by Using Label-Free Multispectral Optoacoustic Tomography</p>. International Journal of Nanomedicine. Volume 14. 9809–9821. 5 indexed citations
20.
Zhang, Yong, Fenxia Li, Fuqiang Liu, et al.. (2016). Elevation of Fasting Ghrelin in Healthy Human Subjects Consuming a High-Salt Diet: A Novel Mechanism of Obesity?. Nutrients. 8(6). 323–323. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026